FDA Inspection 1170084 — Deepak C. D'Souza, M.D.

Deepak C. D'Souza, M.D. — FEI 3021592850

The FDA completed an inspection of Deepak C. D'Souza, M.D. on May 20, 2022 in West Haven, CT. The inspection was classified VAI (Voluntary Action Indicated — objectionable conditions or practices were found, but the agency is not prepared to take or recommend any administrative or regulatory action). 1 citation was issued during this inspection. Product area: Drugs.

Inspection Details

Classification
Voluntary Action Indicated (VAI)
End Date
May 20, 2022
Fiscal Year
2022
Product Type
Drugs
Project Area
Bioresearch Monitoring
Location
West Haven, CT (United States)

Additional Details

Sponsor-Investigator (S-I)

Citations

IDCFRDescription
756021 CFR 312.60FD-1572, protocol compliance